Article info

Download PDFPDF

Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

Authors

  1. a shruti.agrawal{at}bms.com
  2. b yan.feng{at}bms.com
  3. c amit.roy{at}bms.com
  4. d georgia.kollia{at}bms.com
  5. e brian.lestini{at}bms.com
View Full Text

Citation

Agrawal S, Feng Y, Roy A, et al
Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy

Publication history

  • Received September 29, 2016
  • Accepted October 14, 2016
  • First published November 15, 2016.
Online issue publication 
November 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.